The emerging role of mass spectrometry-based proteomics in drug discovery
University of Bonn · Max Planck Institute of Biochemistry · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
340
total citations
- FWCI
- 27.03
- Percentile
- 100%
- References
- 321
Citations per year
Authors
4- FMFelix Meissner
University of Bonn, Max Planck Institute of Biochemistry
- JGJennifer Geddes‐McAlister
Max Planck Institute of Biochemistry, University of Guelph
- MMMatthias Mann
University of Copenhagen, Novo Nordisk Foundation, University of Guelph
- MBMarcus BantscheffCorresponding
Institute for Environmental Studies Weibel & Ness (Germany)
Topics & keywords
Topics
Keywords
- Drug discovery
- Proteomics
- Mass spectrometry
- Computational biology
- Drug
- Chemistry
- Data science
- Pharmacology
No related works found for this paper.